About Cibus, Inc.
https://www.cibus.comCibus, Inc., a agricultural technology company, develops and licenses plant traits to seed companies for royalties.
CEO
Peter R. Beetham
Compensation Summary
(Year 2023)
Salary $208,334
Stock Awards $480,717
Option Awards $129,080
All Other Compensation $344,510
Total Compensation $1,162,641
Industry Biotechnology
Sector Healthcare
Went public July 20, 2017
Full time employees 157
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2023-06-01 | Reverse | 1:5 |
| 2023-04-25 | Reverse | 1:10 |
ETFs Holding This Stock
Summary
Total 15
Showing Top 3 of 15
Ratings Snapshot
Rating : C-
Discounted Cash Flow 1
Return On Equity 1
Return On Assets 1
Debt To Equity 1
Price To Earnings 1
Price To Book 4
Overall Score 1
Most Recent Analyst Grades
Grade Summary
Buy 2
Showing Top 2 of 2
Price Target
Target High $12.5
Target Low $10.5
Target Median $11.5
Target Consensus $11.5
Institutional Ownership
FMR LLC
Shares:7.36M
Value:$14.36M
VANTAGE CONSULTING GROUP INC
Shares:1.14M
Value:$2.23M
BLACKROCK INC.
Shares:986.63K
Value:$1.92M
Summary
% Of Shares Owned 22.96%
Total Number Of Holders 59
Showing Top 3 of 59
Market Cap $108.05 M
52w High $3.40
52w Low $1.09
P/E -0.72
Volume 538.16K
Outstanding Shares 52.71M
About Cibus, Inc.
https://www.cibus.comCibus, Inc., a agricultural technology company, develops and licenses plant traits to seed companies for royalties.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $615K ▼ | $14.66M ▼ | $-23.54M ▲ | -3.83K% ▼ | $-0.44 ▲ | $-14.04M ▲ |
| Q2-2025 | $933K ▼ | $18.88M ▼ | $-25.37M ▲ | -2.72K% ▲ | $-0.61 ▲ | $-16.29M ▲ |
| Q1-2025 | $1.03M ▼ | $42.6M ▲ | $-46.89M ▼ | -4.53K% ▼ | $-2.02 ▼ | $-39.38M ▼ |
| Q4-2024 | $1.21M ▼ | $19.24M ▼ | $-23.1M ▲ | -1.91K% ▲ | $-0.87 ▲ | $-15.91M ▲ |
| Q3-2024 | $1.67M | $202.1M | $-179.97M | -10.8K% | $-7.63 | $-190.91M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $23.89M ▼ | $330.23M ▼ | $278.2M ▲ | $50.4M ▼ |
| Q2-2025 | $36.46M ▲ | $346.2M ▲ | $271.72M ▲ | $72.12M ▲ |
| Q1-2025 | $23.59M ▲ | $335.05M ▼ | $261.09M ▲ | $70.27M ▼ |
| Q4-2024 | $14.43M ▼ | $350.07M ▼ | $252.24M ▲ | $92.16M ▼ |
| Q3-2024 | $28.8M | $367.87M | $246.99M | $108.14M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $-23.54M ▲ | $-11.74M ▲ | $-108K ▼ | $-725K ▼ | $-12.58M ▼ | $-11.85M ▲ |
| Q2-2025 | $-26.56M ▲ | $-13.6M ▼ | $-93K ▲ | $26.56M ▲ | $12.88M ▲ | $-13.7M ▼ |
| Q1-2025 | $-49.39M ▼ | $-11.83M ▲ | $-291K ▼ | $21.27M ▲ | $9.15M ▲ | $-12.12M ▲ |
| Q4-2024 | $-23.1M ▲ | $-13.99M ▼ | $-56K ▲ | $-306K ▼ | $-14.37M ▼ | $-14.05M ▼ |
| Q3-2024 | $-201.46M | $-13.52M | $-355K | $12.65M | $-1.22M | $-13.88M |
Revenue by Products
| Product | Q2-2025 |
|---|---|
 Reportable Segment | $0 ▲ |
CEO
Peter R. Beetham
Compensation Summary
(Year 2023)
Salary $208,334
Stock Awards $480,717
Option Awards $129,080
All Other Compensation $344,510
Total Compensation $1,162,641
Industry Biotechnology
Sector Healthcare
Went public July 20, 2017
Full time employees 157
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2023-06-01 | Reverse | 1:5 |
| 2023-04-25 | Reverse | 1:10 |
ETFs Holding This Stock
Summary
Total 15
Showing Top 3 of 15
Ratings Snapshot
Rating : C-
Discounted Cash Flow 1
Return On Equity 1
Return On Assets 1
Debt To Equity 1
Price To Earnings 1
Price To Book 4
Overall Score 1
Most Recent Analyst Grades
Grade Summary
Buy 2
Showing Top 2 of 2
Price Target
Target High $12.5
Target Low $10.5
Target Median $11.5
Target Consensus $11.5
Institutional Ownership
FMR LLC
Shares:7.36M
Value:$14.36M
VANTAGE CONSULTING GROUP INC
Shares:1.14M
Value:$2.23M
BLACKROCK INC.
Shares:986.63K
Value:$1.92M
Summary
% Of Shares Owned 22.96%
Total Number Of Holders 59
Showing Top 3 of 59